AGENUS INC Preferred Stock Dividends, Income Statement Impact
AGENUS INC (AGEN) reported Preferred Stock Dividends, Income Statement Impact of $54.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsIncomeStatementImpact · last filed 2026-08-07
- AGENUS INC preferred stock dividends, income statement impact for the quarter ending 2026-06-30 was $54.00K, a 0.00% change year-over-year.
- AGENUS INC preferred stock dividends, income statement impact for the quarter ending 2026-03-31 was $54.00K, a 0.00% change year-over-year.
- AGENUS INC preferred stock dividends, income statement impact for the quarter ending 2025-12-31 was $54.00K, a 0.00% change year-over-year.
- AGENUS INC preferred stock dividends, income statement impact for the quarter ending 2025-09-30 was $54.00K, a 0.00% change year-over-year.
- AGENUS INC preferred stock dividends, income statement impact for fiscal 2025 was $216.00K, a 0.47% increase from fiscal 2024.
- AGENUS INC preferred stock dividends, income statement impact for fiscal 2024 was $215.00K, a 0.94% increase from fiscal 2023.
- AGENUS INC preferred stock dividends, income statement impact for fiscal 2023 was $213.00K, a 0.47% increase from fiscal 2022.
- AGENUS INC preferred stock dividends, income statement impact for fiscal 2022 was $212.00K, a 0.47% increase from fiscal 2021.
| Period end | Preferred Stock Dividends, Income Statement Impact 3 month | Preferred Stock Dividends, Income Statement Impact 3 month as first filed | Preferred Stock Dividends, Income Statement Impact 6 month | Preferred Stock Dividends, Income Statement Impact 6 month as first filed | Preferred Stock Dividends, Income Statement Impact 9 month | Preferred Stock Dividends, Income Statement Impact 9 month as first filed | Preferred Stock Dividends, Income Statement Impact 12 month | Preferred Stock Dividends, Income Statement Impact 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $54.00K 10-Q · filed 2026-08-07 | $109.00K 10-Q · filed 2026-08-07 | $162.00K derived: sum of 3 quarters · filed 2026-08-07 | $216.00K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $54.00K 10-Q · filed 2026-05-11 | $108.00K derived: sum of 2 quarters · filed 2026-05-11 | $162.00K derived: sum of 3 quarters · filed 2026-05-11 | $216.00K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $108.00K derived: sum of 2 quarters · filed 2026-03-16 | $162.00K derived: sum of 3 quarters · filed 2026-08-07 | $216.00K 10-K · filed 2026-03-16 | ||||
| 2025-09-30 | $54.00K 10-Q · filed 2025-11-10 | $108.00K derived: sum of 2 quarters · filed 2026-08-07 | $162.00K 10-Q · filed 2025-11-10 | $216.00K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $54.00K 10-Q · filed 2026-08-07 | $108.00K 10-Q · filed 2026-08-07 | $162.00K derived: sum of 3 quarters · filed 2026-08-07 | $216.00K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $54.00K 10-Q · filed 2026-05-11 | $108.00K derived: sum of 2 quarters · filed 2026-05-11 | $162.00K derived: sum of 3 quarters · filed 2026-05-11 | $216.00K derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $108.00K derived: sum of 2 quarters · filed 2026-03-16 | $162.00K derived: sum of 3 quarters · filed 2026-03-16 | $215.00K 10-K · filed 2026-03-16 | ||||
| 2024-09-30 | $54.00K 10-Q · filed 2025-11-10 | $108.00K derived: sum of 2 quarters · filed 2025-11-10 | $161.00K 10-Q · filed 2025-11-10 | $215.00K derived: sum of 4 quarters · filed 2026-03-16 | ||||
| 2024-06-30 | $54.00K 10-Q · filed 2025-08-11 | $107.00K 10-Q · filed 2025-08-11 | $161.00K derived: sum of 3 quarters · filed 2026-03-16 | $214.00K derived: sum of 4 quarters · filed 2026-03-16 | ||||
| 2024-03-31 | $54.00K 10-Q · filed 2025-05-12 | $107.00K derived: sum of 2 quarters · filed 2026-03-16 | $160.00K derived: sum of 3 quarters · filed 2026-03-16 | $213.00K derived: sum of 4 quarters · filed 2026-03-16 | ||||
| 2023-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $106.00K derived: sum of 2 quarters · filed 2026-03-16 | $159.00K derived: sum of 3 quarters · filed 2026-03-16 | $213.00K 10-K · filed 2026-03-16 | ||||
| 2023-09-30 | $53.00K 10-Q · filed 2024-11-12 | $106.00K derived: sum of 2 quarters · filed 2024-11-12 | $160.00K 10-Q · filed 2024-11-12 | $212.00K derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-06-30 | $53.00K 10-Q · filed 2024-08-08 | $107.00K 10-Q · filed 2024-08-08 | $159.00K derived: sum of 3 quarters · filed 2025-03-17 | $212.00K derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-03-31 | $53.00K 10-Q · filed 2024-05-07 | $106.00K derived: sum of 2 quarters · filed 2025-03-17 | $159.00K derived: sum of 3 quarters · filed 2025-03-17 | $212.00K derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2022-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $106.00K derived: sum of 2 quarters · filed 2025-03-17 | $159.00K derived: sum of 3 quarters · filed 2025-03-17 | $212.00K 10-K · filed 2025-03-17 | ||||
| 2022-09-30 | $53.00K 10-Q · filed 2023-11-09 | $106.00K derived: sum of 2 quarters · filed 2023-11-09 | $159.00K 10-Q · filed 2023-11-09 | $212.00K derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2022-06-30 | $53.00K 10-Q · filed 2023-08-08 | $106.00K 10-Q · filed 2023-08-08 | $159.00K derived: sum of 3 quarters · filed 2024-03-14 | $212.00K derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2022-03-31 | $53.00K 10-Q · filed 2023-05-09 | $106.00K derived: sum of 2 quarters · filed 2024-03-14 | $159.00K derived: sum of 3 quarters · filed 2024-03-14 | $212.00K derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2021-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $106.00K derived: sum of 2 quarters · filed 2024-03-14 | $159.00K derived: sum of 3 quarters · filed 2024-03-14 | $211.00K 10-K · filed 2024-03-14 | ||||
| 2021-09-30 | $53.00K 10-Q · filed 2022-11-08 | $106.00K derived: sum of 2 quarters · filed 2022-11-08 | $158.00K 10-Q · filed 2022-11-08 | $211.00K derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-06-30 | $53.00K 10-Q · filed 2022-08-09 | $105.00K 10-Q · filed 2022-08-09 | $158.00K derived: sum of 3 quarters · filed 2023-03-16 | $210.00K derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2021-03-31 | $53.00K 10-Q · filed 2022-05-10 | $105.00K derived: sum of 2 quarters · filed 2023-03-16 | $157.00K derived: sum of 3 quarters · filed 2023-03-16 | $209.00K derived: sum of 4 quarters · filed 2023-03-16 | ||||
| 2020-12-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $104.00K derived: sum of 2 quarters · filed 2023-03-16 | $156.00K derived: sum of 3 quarters · filed 2023-03-16 | $209.00K 10-K · filed 2023-03-16 | ||||
| 2020-09-30 | $52.00K 10-Q · filed 2021-11-09 | $104.00K derived: sum of 2 quarters · filed 2021-11-09 | $157.00K 10-Q · filed 2021-11-09 | $208.00K derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $52.00K 10-Q · filed 2021-08-09 | $105.00K 10-Q · filed 2021-08-09 | $156.00K derived: sum of 3 quarters · filed 2022-03-01 | $208.00K derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $52.00K 10-Q · filed 2021-05-07 | $104.00K derived: sum of 2 quarters · filed 2022-03-01 | $156.00K derived: sum of 3 quarters · filed 2022-03-01 | $208.00K derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $104.00K derived: sum of 2 quarters · filed 2022-03-01 | $156.00K derived: sum of 3 quarters · filed 2022-03-01 | $208.00K 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $52.00K 10-Q · filed 2020-11-09 | $104.00K derived: sum of 2 quarters · filed 2020-11-09 | $156.00K 10-Q · filed 2020-11-09 | $208.00K derived: sum of 4 quarters · filed 2021-03-16 | ||||
| 2019-06-30 | $52.00K 10-Q · filed 2020-08-10 | $104.00K 10-Q · filed 2020-08-10 | $156.00K derived: sum of 3 quarters · filed 2021-03-16 | $208.00K derived: sum of 4 quarters · filed 2021-03-16 | ||||
| 2019-03-31 | $52.00K 10-Q · filed 2020-05-11 | $104.00K derived: sum of 2 quarters · filed 2021-03-16 | $156.00K derived: sum of 3 quarters · filed 2021-03-16 | $208.00K derived: sum of 4 quarters · filed 2021-03-16 | ||||
| 2018-12-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $104.00K derived: sum of 2 quarters · filed 2021-03-16 | $156.00K derived: sum of 3 quarters · filed 2021-03-16 | $207.00K 10-K · filed 2021-03-16 | $206.84K 10-K · filed 2019-03-18 | |||
| 2018-09-30 | $52.00K 10-Q · filed 2019-11-07 | $51.75K 10-Q · filed 2018-11-07 | $104.00K derived: sum of 2 quarters · filed 2019-11-07 | $155.00K 10-Q · filed 2019-11-07 | $155.01K 10-Q · filed 2018-11-07 | $207.97K derived: sum of 4 quarters · filed 2020-03-16 | ||
| 2018-06-30 | $52.00K 10-Q · filed 2019-08-09 | $51.67K 10-Q · filed 2018-08-09 | $103.00K 10-Q · filed 2019-08-09 | $103.26K 10-Q · filed 2018-08-09 | $155.97K derived: sum of 3 quarters · filed 2020-03-16 | $207.39K derived: sum of 4 quarters · filed 2020-03-16 | ||
| 2018-03-31 | $52.00K 10-Q · filed 2019-05-10 | $51.59K 10-Q · filed 2018-05-10 | $103.97K derived: sum of 2 quarters · filed 2020-03-16 | $155.39K derived: sum of 3 quarters · filed 2020-03-16 | $206.74K derived: sum of 4 quarters · filed 2020-03-16 | |||
| 2017-12-31 | $51.97K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $103.39K derived: sum of 2 quarters · filed 2020-03-16 | $154.74K derived: sum of 3 quarters · filed 2020-03-16 | $206.00K 10-K · filed 2020-03-16 | $205.54K 10-K · filed 2018-03-16 | |||
| 2017-09-30 | $51.43K 10-Q · filed 2018-11-07 | $102.77K derived: sum of 2 quarters · filed 2018-11-07 | $154.03K 10-Q · filed 2018-11-07 | $205.22K derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-06-30 | $51.34K 10-Q · filed 2018-08-09 | $102.61K 10-Q · filed 2018-08-09 | $153.79K derived: sum of 3 quarters · filed 2019-03-18 | $204.89K derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-03-31 | $51.26K 10-Q · filed 2018-05-10 | $102.45K derived: sum of 2 quarters · filed 2019-03-18 | $153.55K derived: sum of 3 quarters · filed 2019-03-18 | $204.57K derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2016-12-31 | $51.18K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $102.28K derived: sum of 2 quarters · filed 2019-03-18 | $153.31K derived: sum of 3 quarters · filed 2019-03-18 | $204.25K 10-K · filed 2019-03-18 | ||||
| 2016-09-30 | $51.10K 10-Q · filed 2017-11-07 | $102.12K derived: sum of 2 quarters · filed 2017-11-07 | $153.06K 10-Q · filed 2017-11-07 | $203.93K derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-06-30 | $51.02K 10-Q · filed 2017-08-07 | $101.96K 10-Q · filed 2017-08-07 | $152.82K derived: sum of 3 quarters · filed 2018-03-16 | $203.60K derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-03-31 | $50.94K 10-Q · filed 2017-05-04 | $101.80K derived: sum of 2 quarters · filed 2018-03-16 | $152.58K derived: sum of 3 quarters · filed 2018-03-16 | |||||
| 2015-12-31 | $50.86K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $101.64K derived: sum of 2 quarters · filed 2018-03-16 | $202.96K 10-K · filed 2018-03-16 | |||||
| 2015-09-30 | $50.78K 10-Q · filed 2016-11-09 | $152.10K 10-Q · filed 2016-11-09 | ||||||
| 2014-12-31 | $203.83K 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |